Comparison between Atmastco IPO and Zenith Drugs IPO.
IPO Details
Atmastco IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Atmastco IPO is up to ₹53.43 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Atmastco IPO is ₹77.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| | Atmastco IPO | Zenith Drugs IPO |
|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | | ₹75.00 per share |
| Issue Price (Upper) | | ₹79.00 per share |
| Issue Price (Final) | ₹77.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | | |
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 51,13,600 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹39.37 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 18,25,600 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹14.06 Cr | up to ₹0.00 Cr |
| Issue Size Total | 69,39,200 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹53.43 Cr | up to ₹33.94 Cr |
IPO Timetable
Atmastco IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Atmastco IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.
| | Atmastco IPO | Zenith Drugs IPO |
|---|
| Anchor Bid Date | | Feb 16, 2024 |
| Issue Open | Feb 15, 2024 | Feb 19, 2024 |
| Issue Close | Feb 20, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 21, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Feb 23, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | | Mar 24, 2024 |
| Anchor Lockin End date 2 | | May 23, 2024 |
Financials & KPIs
Atmastco IPO P/E ratio is 11.6, as compared to Zenith Drugs IPO P/E ratio of 18.4.
Shares Offered
In the Atmastco IPO Retail Individual Investors (RII) are offered 34,69,600 shares while in Zenith Drugs IPO retail investors are offered 34,69,600 shares. Qualified Institutional Buyers (QIB) are offered in Atmastco IPO and 8,59,200 shares in Zenith Drugs IPO.
| | Atmastco IPO | Zenith Drugs IPO |
|---|
| Anchor Investor Reservation | | 12,88,000 shares |
| Market Maker Reservation | 3,66,400 shares | 8,52,800 shares |
| QIB | | 8,59,200 shares |
| NII | 34,69,600 shares | 6,44,800 shares |
| RII | 34,69,600 shares | 15,04,000 shares |
| Employee | | |
| Others | | |
| Total | 69,39,200 shares | 42,96,000 shares |
Bids Received (Subscription)
Atmastco IPO subscribed 17.61x in total, whereas Zenith Drugs IPO subscribed 179.18x.
